Overview
Comparison of clinical outcomes between routine angiography follow-up and routine clinical follow-up after percutaneous coronary intervention in high-risk patients.
Eligibility
Inclusion Criteria:
- Age ≥ 18 years.
- Successful PCI with at least two of the following high-risk factors:
- Left main lesion; B. Bifurcation lesion (true bifurcation); C. Ostial lesion of main
vessels (left anterior descending, left circumflex artery, right coronary artery); D.
Chronic total occlusion; E. Multivessel revascularization (≥ 2 vessels); F. In-stent
restenosis; G. Diffuse long lesion (lesion length ≥ 30 mm or stent length ≥ 38 mm); H.
Severe calcified lesion (Significant severe calcification on angiography); I. Bypass graft
lesion; J. Diabetes mellitus; K. Chronic kidney disease (defined as an estimated glomerular
filtration rate of <30 ml per minute per 1.73 m2 of body-surface area or the receipt of
dialysis); L. Myocardial infarction;
- He/she or his/her legally authorized representative provides written informed
- Left main lesion; B. Bifurcation lesion (true bifurcation); C. Ostial lesion of main
vessels (left anterior descending, left circumflex artery, right coronary artery); D.
Chronic total occlusion; E. Multivessel revascularization (≥ 2 vessels); F. In-stent
restenosis; G. Diffuse long lesion (lesion length ≥ 30 mm or stent length ≥ 38 mm); H.
Severe calcified lesion (Significant severe calcification on angiography); I. Bypass graft
lesion; J. Diabetes mellitus; K. Chronic kidney disease (defined as an estimated glomerular
filtration rate of <30 ml per minute per 1.73 m2 of body-surface area or the receipt of
dialysis); L. Myocardial infarction;
Exclusion Criteria:
- Revascularization with bare metal stents and/or balloon angioplasty with non-drug-coated balloons.
- Pregnant and/or lactating women.
- Life expectancy of less than 2 years.
- Repeat interventional therapy is planned.
- Subject was unable to provide written informed consent.